| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 0% stake in VistaGen Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 0% stake in Jiya Acquisition Corp. |
| 02/14/2023 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 0% stake in BCLS Acquisition Corp. |
| 02/15/2022 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 5.9% stake in VistaGen Therapeutics, Inc. |
| 02/15/2022 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 5.7% stake in BCLS Acquisition Corp. |
| 02/15/2022 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 0% stake in Larimar Therapeutics Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/07/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/22/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 4.6% stake in KADMON HOLDINGS, INC. |
| 11/12/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2019 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 1.1% stake in VERACYTE INC |
| 02/13/2019 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 7.8% stake in KADMON HOLDINGS, INC. |
| 02/13/2019 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 8.6% stake in IRIDEX CORPORATION |
| 02/13/2019 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 2.5% stake in IOVANCE BIOTHERAPEUTICS, INC. |
| 02/13/2019 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 0% stake in CATALYST BIOSCIENCES, INC. |
| 02/13/2019 |
SC 13G
| ACUTA CAPITAL PARTNERS, LLC reports a 18.2% stake in CAS MEDICAL SYSTEMS, INC. |
| 02/13/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/09/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/08/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/02/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/02/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/02/2017 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 6.4% stake in IOVANCE BIOTHERAPEUTICS, INC. |
| 06/09/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|